Finance

Lists
Q3 2026 earnings • in 4 days
See details
PRVA:NASDAQ
Privia Health Group Inc
$21.48
-2.34%
(-0.52) 1D
$21.48
0.00% (0.00)
After hours
Closed: Oct 30, 3:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRVA...
Open
$22.10
High
$22.10
Low
$21.30
Mkt. cap
2.74B
Avg. vol.
1.24M
Volume
841.16K
P/E ratio
99.67
52-wk high
$28.82
52-wk low
$18.92
EPS
$0.22
Beta
0.80
Shares outstanding
127.73M
No. of employees
1K
Open
$22.10
High
$22.10
Low
$21.30
Mkt. cap
2.74B
Avg. vol.
1.24M
Volume
841.16K
P/E ratio
99.67
52-wk high
$28.82
52-wk low
$18.92
EPS
$0.22
Beta
0.80
Shares outstanding
127.73M
No. of employees
1K
News stories
From web sources and news partners
About Privia Health Group Inc
CEO-
Employees1.23K
Founded2007
Headquarters-
SectorHealth care provider
Websitepriviahealth.com
Analyst ratings
Based on 11 analysts giving stock ratings to PRVA in the past 3 months
Strong buy
Buy
10
Hold
1
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for PRVA in the last 3 months.
Highest
Current $21.48
$36.00 (+67.60%)
Average
$31.80 (+48.04%)
Lowest
$24.00 (+11.73%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Halsted
RBC Capital
Buy
Maintained
$31.00
+44.3%
10/06/2026
Unknown Analyst
Jefferies
Buy
Maintained
$30.00
+39.7%
09/16/2026
Andrew Mok CFA
Barclays
Hold
Maintained
$24.00
+11.7%
08/28/2026
Jailendra Singh
Truist Financial
Buy
Maintained
$33.00
+53.6%
08/13/2026
Daniel Grosslight
Citi
Buy
Reiterated
$35.00
+62.9%
08/10/2026
David Larsen
BTIG
Buy
Maintained
$35.00
+62.9%
08/09/2026
Sean Dodge
BMO Capital
Buy
Maintained
$30.00
+39.7%
08/07/2026
Jessica Tassan
Piper Sandler
Buy
Maintained
$36.00
+67.6%
08/07/2026
Richard Close
Canaccord Genuity
Buy
Maintained
$32.00
+49%
08/07/2026
Ryan Daniels
William Blair
Buy
Reiterated
-
-
08/06/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
$32.00
+49%
08/06/2026
Ryan Langston
TD Cowen
Buy
Maintained
$30.00
+39.7%
05/11/2026
Matthew Shea
Needham
Buy
Reiterated
$30.00
+39.7%
05/07/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
$35.00
+62.9%
03/06/2026
Unknown Analyst
BTIG
Buy
Maintained
$35.00
+62.9%
03/05/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
-
-
02/27/2026
Jack Slevin
Jefferies
Buy
Reiterated
$32.00
+49%
02/26/2026
Next call in 4 days
Thu, Nov 5, 3:00 PM
Fiscal period
Q3 2026
- / $0.24
Revenue / Est. (USD)
- / 610.62M
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
580.42M
541.17M
603.85M
632.63M
Cost of goods sold
516.65M
491.52M
543.54M
569.84M
Cost of revenue
516.65M
491.52M
543.54M
569.84M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
46.60M
35.72M
49.61M
47.66M
Operating expense
49.37M
38.38M
52.89M
51.02M
Total operating expenses
566.02M
529.90M
596.42M
620.86M
Operating income
14.40M
11.28M
7.42M
11.77M
Other non operating income
-
-
-
3.31M
EBT including unusual items
16.67M
13.37M
9.31M
16.75M
EBT excluding unusual items
16.67M
13.37M
9.31M
16.75M
Income tax expense
6.87M
2.79M
5.60M
7.02M
Effective tax rate
41.18%
20.84%
60.15%
41.89%
Other operating expenses
-
-
-
-
Net income
6.86M
9.15M
3.06M
9.05M
Net profit margin
1.18%
1.69%
0.51%
1.43%
Earnings per share
0.29
0.25
0.19
0.19
Interest and investment income
2.27M
2.09M
1.89M
1.67M
Interest expense
-
-
-
-
Net interest expenses
2.27M
2.09M
1.89M
1.67M
Depreciation and amortization charges
2.77M
2.66M
3.28M
3.36M
EBITDA
17.17M
13.94M
10.70M
15.13M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps